Journals / Journal of the Turkish-German Gynecological Association / 2009 / Cilt: 10 - Sayı: 2

Erken ve geç gebelik sonlandırmalarında kombine misoprostol uygulamasının etkinliği

Efficacy of combined administration of misoprostol for early and late second trimester pregnancy terminations

Pages
76–79
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Early and late second trimester pregnancy terminations had similar clinical features except for decreased surgical evacuation rate of uterine cavity in women with more than 20 weeks of gestation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To compare the effectiveness of combined oral and vaginal misoprostol administration between the early and late second-trimester pregnancy terminations.Material and Methods: Demographic and clinical data of 257 second trimester pregnancy terminations were retrospectively reviewed.
📊
Key Findings & Data:A total of 257 patients were divided into the 2 groups.
💡
Conclusion & Impact:Conclusion: Early and late second trimester pregnancy terminations had similar clinical features except for decreased surgical evacuation rate of uterine cavity in women with more than 20 weeks of gestation.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To compare the effectiveness of combined oral and vaginal misoprostol administration between the early and late second-trimester pregnancy terminations.Material and Methods: Demographic and clinical data of 257 second trimester pregnancy terminations were retrospectively reviewed. A total of 257 patients were divided into the 2 groups. Group 1 was composed of 131 women whose gestational age was lower than 20 weeks of gestation. Group 2 was formed from 126 women whose gestational age was more than the 20 weeks and one day of gestation. Demographic data, gestational age at diagnosis, total misoprostol dose (µg), induction to abortion or delivery period, total hospital stay, need for uterine cavity exploration and, complications were compared. Primary outcome was termination of pregnancy within the 24 hours. Results: The median induction to abortion or delivery period was 13.35 hours and 14.23 hours respectively (p=0.37). Eighty-seven percent of pregnancies in group 1 and 88.8 % of group 2 were terminated within 24 hours (p=0.64). Dilatation and curettage was required in 59.3 % of group 1 and 40.7% of group 2 (p=0.032). Only total misoprostol dose was related with the delivery within 24 hours (p=0.001). This time interval was not related with indication of pregnancy termination (p=0.74). Conclusion: Early and late second trimester pregnancy terminations had similar clinical features except for decreased surgical evacuation rate of uterine cavity in women with more than 20 weeks of gestation.

Özet

Amaç: Erken ve geç ikinci trimester gebelik sonlandırmalarında kombine oral ve vajinal misoprostol uygulamasının etkinliğinin karşılaştırılması Gereç ve Yöntemler: Gebelik sonlandırması yapılan toplam 257 hastaya ait demografik ve klinik veriler retrospektif olarak gözden geçirildi. Toplam 257 olgu, iki gruba ayrıldı. Gestasyonel yaşı 20. Gebelik haftasından küçük 131 olgu grup 1’i meydana getirirken, gestasyonel yaşı 20 hafta 1 günün üzerinde olan 126 olgu grup 2’yi meydana getirdi. Bu gruplara ait demografik veriler, tanı sırasındaki gebelik yaşı, toplam mizoprostol dozu, indüksiyondan abortusa veya doğuma kadar geçen süre, toplam hastanede kalış süresi ve uterin kavitenin eksplorasyonunun gerektiği olgu sayısı karşılaştırıldı. Birincil değerlendirme ölçütü, 24 saat içinde gebeliğin sonlanmasıydı. Bulgular: İndüsiyondan abortus veya doğuma kadar geçen medyan süre erken ilk grupta 13.35 saat, ikincir grupta ise 14.23 saatti (p=0.37). Grup 1’de olguların % 85.7’ si, Grup 2‘de ise % 88.8’ i 24 saat içinde sonlandı (p=0.64). Uterin kavitenin eksplorasyonu, grup 1’de % 59.3 grup 2’de ise % 40.7 oranında gerçekleşti (p=0.0.32). Değerlendirilen faktörlerden sadece toplam misoprostol dozu, 24 saat içinde gebeliğin sonlanması ile ilişkiliydi (p=0.001). Sonlandırma endikasyonu ile gebelik sonladırmasına kadar geçen süre arasında, ilişki izlenmedi (p=0.74). Sonuç: Erken ve geç 2. trimester gebelik sonlandırmaları, uterin kavitenin eksplorasyonu gereksinimi dışında benzer klinik özelliklere sahiptir.

🔖

Cite This Article

ÖZTÜRK, İ., DİLEK, S., CAYAN, F., DİLEK, T. U. K., DURUKAN, H. (2022). Erken ve geç gebelik sonlandırmalarında kombine misoprostol uygulamasının etkinliği. Journal of the Turkish-German Gynecological Association, Cilt: 10 - Sayı: 2, 76–79. https://ajindex.com/articles/567814

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gardner DK, Lane M. Culture and selection of viable blastocysts: a 1. Hinman JW. Developing applications of prostaglandins in obstetrics and gynecology. Am J Obstet Gynecol 1972; 113: 130-28
  2. Scheepers HCJ, van Erp EJM, van der Bergh AS. Use of misoprostol in first and second trimester abortion: a review. Obstet Gynecol Surv 1999; 54: 592-600
  3. Ngai SW, Tang OS, Ho PC. Prostaglandins for induction of second-trimester termination and intrauterine death. Best Prac Res Clin Obstet Gynaecol. 2003; 17: 765-75
  4. Ho PC, Ngai SW, Liu KL, Wong GC, Lee SW. Vaginal misoprostol compared with oral misoprostol in termination of second trimester pregnancy. Obstet Gynecol 1997; 90: 735-8
  5. Bebbington MW, Kent N, Lim K, et al. A randomized controlled trial comparing two protocols for the use of misoprostol in midtrimester pregnancy termination. Am J Obstet Gynecol 2002; 187: 853-7 6. Jain JK, Mishell DR. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med 1994; 331: 290-3
  6. Dickinson JE, Godfrey M, Evans SF. Efficacy of intravaginal misoprostol in second-trimester pregnancy termination: a randomized controlled trial. J Matern Fetal Med 1998; 7: 115-9
  7. Herabutya Y, Chanrachakul B, Punyavachira P. Vaginal misoprostol in termination of second trimester pregnancy. J Obstet Gynaecol Res 2000; 26: 121-5
  8. Ramin KD, Ogburn PL, Danilenko DR, Ramsey PS. High-dose oral misoprostol for mid-trimester pregnancy interruption. Gynecol Obstet Invest 2002; 54: 176-9
  9. Dickinson JE, Evans SF. The optimization of intravaginal misoprostol dosing schedules in second-trimester pregnancy termination. Am J Obstet Gynecol 2002; 186: 470-4
  10. Borgida, AF, Rodis JF, Hanlon W, et al. Second trimester abortion by intramuscular 15-methyl prostaglandin F2 or intravaginal prostaglandin F2 suppositories: a randomized controlled trial. Obstet Gynecol 1995; 85: 697-700
  11. Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol 1997; 90: 88-92
  12. Akoury, BA, Hannah ME, Chityat D, et al. Randomized controlled trial of misoprostol for second trimester pregnancy termination associated with fetal malformation. Am J Obstet Gynecol 2004; 190: 755-62
  13. Fadalla FA, Mirghani OA, Adam I. Oral misoprostol vs. vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second trimester. Int J Gynecol Obstet